Skip to main content
Login
Contact
Subscribe
Search form
Search
The Antlers American
Home
Forms
News
Sports
Classifieds
Obituaries
Entertainment
Special Sections
Talking About...
Photos
Videos
Games
Community Links
Pushmataha County Chamber
Antlers Public Schools
Clayton Public School
Deer Capitol Tourism Association
Little Dixie Community Action Agency
Moyers Public School
Rattan Public Schools
Wildlife Heritage Center
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
NYSE COMPOSITE INDX
Gold
Crude Oil
GALECTIN RG
(NQ:
GALT
)
5.620
USD
-0.200 (-3.44%)
Official Closing Price
/ Updated:
8:00 PM EDT, Jul 20, 2018
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
516,877
Open
5.800
Bid (Size)
5.500 (1300)
Ask (Size)
5.690 (100)
Prev. Close
5.820
Today's Range
5.570 - 5.895
52wk Range
1.280 - 9.490
Shares Outstanding
37,740,647
Dividend Yield
N/A
Performance
YTD
+45.60%
+45.60%
1 Month
-27.11%
-27.11%
3 Month
+62.90%
+62.90%
6 Month
+7.66%
+7.66%
1 Year
+157.80%
+157.80%
Top News
More News
Galectin Therapeutics Receives Patent for GR-MD-02 Patent for Method and Treatment of Pulmonary Fibrosis
June 27, 2018
Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that the Company has received notice of...
Read More
from
GlobeNewswire News Releases
Company Profile for Galectin Therapeutics Inc.
June 22, 2018
Galectin Therapeutics is dedicated to developing novel therapies to improve the lives of patients with chronic liver disease and cancer. Galectin's lead drug (GR-MD-02) is a carbohydrate drug that...
Read More
category
Galectin Therapeutics Inc.
from
Business Wire News Releases
More News
Read More
Mid-Day Market Update: Crude Oil Up Over 3%; Aquinox Pharmaceuticals Shares Plunge
June 27, 2018
category
SDRL
,
PTIE
,
Market News
, and 16 more.
from
Benzinga
Mid-Morning Market Update: Markets Open Higher; Conagra To Acquire Pinnacle Foods
June 27, 2018
category
SDRL
,
PTIE
,
RKDA
, and 16 more.
from
Benzinga
Why Galectin Therapeutics Stock Bolted Higher Today
June 27, 2018
category
GALT
,
Market News
from
Motley Fool
GALT Crosses Above Average Analyst Target
June 18, 2018
category
ETFs
from
ETF Channel
2 Clinical-Stage Biotech Stocks That Could Soar Next Week
June 17, 2018
category
GALT
,
VSTM
,
Market News
from
Motley Fool
Mid-Day Market Update: Pivotal Software Gains Following Q1 Results; Flex Pharma Shares Slide
June 13, 2018
category
Eurozone
,
HRB
,
SEII
, and 16 more.
from
Benzinga
3 Biotech Stocks That Soared This Week: Are They Buys?
June 16, 2018
category
GLMD
,
Market News
,
GALT
from
Motley Fool
3 NASH Stocks That Could Soar in the Second Half of 2018
June 15, 2018
category
Market News
,
GALT
,
MDGL
, and 2 more.
from
Motley Fool
42 Biggest Movers From Yesterday
July 06, 2018
category
AUTL
,
MXC
,
PRAN
, and 51 more.
from
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
